Pages that link to "Q69657848"

The following pages link to CB 1954 (2,4-dinitro-5-aziridinyl benzamide) becomes a DNA interstrand crosslinking agent in Walker tumour cells (Q69657848):

Displaying 14 items.

• Cone degeneration following rod ablation in a reversible model of retinal degeneration (Q30498458) (← links)
• Hypoxia-Specific Cytotoxins in Cancer Therapy (Q33862670) (← links)
• Antibody-directed enzyme prodrug therapy (ADEPT): a review (Q33933108) (← links)
• The role of NAD(P)H oxidoreductase (DT-Diaphorase) in the bioactivation of quinone-containing antitumor agents: a review (Q34062707) (← links)
• Pineal photoreceptor cells are required for maintaining the circadian rhythms of behavioral visual sensitivity in zebrafish (Q34344872) (← links)
• A novel model of retinal ablation demonstrates that the extent of rod cell death regulates the origin of the regenerated zebrafish rod photoreceptors (Q36850729) (← links)
• Escherichia coli nitroreductase plus CB1954 enhances the effect of radiotherapy in vitro and in vivo (Q40035482) (← links)
• The bioactivation of CB 1954 and its use as a prodrug in antibody-directed enzyme prodrug therapy (ADEPT). (Q40848135) (← links)
• Sensitisation of human carcinoma cells to the prodrug CB1954 by adenovirus vector-mediated expression of E. coli nitroreductase. (Q40875506) (← links)
• Antibody directed enzymes revive anti-cancer prodrugs concept (Q41153114) (← links)
• The Walker 256 carcinoma: a cell type inherently sensitive only to those difunctional agents that can form DNA interstrand crosslinks (Q41658787) (← links)
• Professor Tom Connors and the development of novel cancer therapies by the Phase I/II Clinical Trials Committee of Cancer Research UK. (Q43236564) (← links)
• Inhibition of myc-dependent breast tumor formation in transgenic mice (Q43892058) (← links)
• Prodrugs in Cancer Chemotherapy (Q73429925) (← links)